ITSN1 and inflammatory bowel disease: Thus, we further validated lnc-ITSN1-2 expression in both intestinal mucosa and PBMC samples from 120 IBD (including 30 A-CD, 30 R-CD, 30 A-UC, and 30 R-UC) patients and 30 HCs using RT-qPCR.